175 related articles for article (PubMed ID: 16199111)
1. Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens.
Delbecq S; Hadj-Kaddour K; Randazzo S; Kleuskens J; Schetters T; Gorenflot A; Précigout E
Vaccine; 2006 Jan; 24(5):613-21. PubMed ID: 16199111
[TBL] [Abstract][Full Text] [Related]
2. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
3. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.
Figueroa JV; Precigout E; Carcy B; Gorenflot A
Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
[TBL] [Abstract][Full Text] [Related]
5. Association between sequence polymorphism in an epitope of Babesia divergens Bd37 exoantigen and protection induced by passive transfer.
Precigout E; Delbecq S; Vallet A; Carcy B; Camillieri S; Hadj-Kaddour K; Kleuskens J; Schetters T; Gorenflot A
Int J Parasitol; 2004 Apr; 34(5):585-93. PubMed ID: 15064123
[TBL] [Abstract][Full Text] [Related]
6. Recombinant protein Bd37 protected gerbils against heterologous challenges with isolates of Babesia divergens polymorphic for the bd37 gene.
Hadj-Kaddour K; Carcy B; Vallet A; Randazzo S; Delbecq S; Kleuskens J; Schetters T; Gorenflot A; Precigout E
Parasitology; 2007 Feb; 134(Pt 2):187-96. PubMed ID: 17038236
[TBL] [Abstract][Full Text] [Related]
7. Babesia divergens vaccine.
Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
[TBL] [Abstract][Full Text] [Related]
8. Babesia divergens experimental infection of spleen-intact sheep results in long-lasting parasitemia despite a strong humoral response: preliminary results.
Moreau E; Jouglin M; Chauvin A; Malandrin L
Vet Parasitol; 2009 Dec; 166(3-4):205-11. PubMed ID: 19765903
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of older Bos taurus bulls against bovine babesiosis.
Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
[TBL] [Abstract][Full Text] [Related]
10. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
[TBL] [Abstract][Full Text] [Related]
11. The solution structure of the adhesion protein Bd37 from Babesia divergens reveals structural homology with eukaryotic proteins involved in membrane trafficking.
Delbecq S; Auguin D; Yang YS; Löhr F; Arold S; Schetters T; Précigout E; Gorenflot A; Roumestand C
J Mol Biol; 2008 Jan; 375(2):409-24. PubMed ID: 18035372
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against canine babesiosis.
Schetters T
Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity.
Carcy B; Précigout E; Schetters T; Gorenflot A
Vet Parasitol; 2006 May; 138(1-2):33-49. PubMed ID: 16551492
[TBL] [Abstract][Full Text] [Related]
14. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
[TBL] [Abstract][Full Text] [Related]
15. Designing blood-stage vaccines against Babesia bovis and B. bigemina.
Brown WC; Palmer GH
Parasitol Today; 1999 Jul; 15(7):275-81. PubMed ID: 10377530
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and vaccination strategy: Babesia divergens bovine babesiosis example.
L'Hostis M
Vet Res; 1995; 26(3):240-3. PubMed ID: 7795691
[No Abstract] [Full Text] [Related]
17. Vaccination against babesiosis using recombinant GPI-anchored proteins.
Nathaly Wieser S; Schnittger L; Florin-Christensen M; Delbecq S; Schetters T
Int J Parasitol; 2019 Feb; 49(2):175-181. PubMed ID: 30684517
[TBL] [Abstract][Full Text] [Related]
18. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
[TBL] [Abstract][Full Text] [Related]
19. A 37-kilodalton glycoprotein of Babesia divergens is a major component of a protective fraction containing low-molecular-mass culture-derived exoantigens.
Carcy B; Precigout E; Valentin A; Gorenflot A; Schrevel J
Infect Immun; 1995 Mar; 63(3):811-7. PubMed ID: 7868251
[TBL] [Abstract][Full Text] [Related]
20. Babesia gibsoni ribosomal phosphoprotein P0 induces cross-protective immunity against B. microti infection in mice.
Terkawi MA; Jia H; Zhou J; Lee EG; Igarashi I; Fujisaki K; Nishikawa Y; Xuan X
Vaccine; 2007 Mar; 25(11):2027-35. PubMed ID: 17229504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
